CD34 is a drug target for AML and CML

ABSTRACT: EGFR inhibitors selectively kill CD34+ leukemia cells and induced clinical remission in patients with high percentage of CD34+ blast

ORGANISM(S): Homo Sapiens

SUBMITTER: Ying Lu  

PROVIDER: PXD023328 | iProX | Wed Dec 30 00:00:00 GMT 2020

REPOSITORIES: iProX